Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1986 Jan;29(1):20–25. doi: 10.1128/aac.29.1.20

Activity of 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil against simian varicella virus infections in African green monkeys.

K F Soike, C Cantrell, P J Gerone
PMCID: PMC180356  PMID: 3729332

Abstract

The fluorinated pyrimidines 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil (FIAU) and 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-methyluracil (FMAU) are highly effective inhibitors of herpesvirus infections in vitro and in vivo. This report is concerned with an evaluation of their activities in African green monkeys (Cercopithecus aethiops) infected with simian varicella virus, a herpesvirus closely related to human varicella-zoster virus. Oral or intravenous administration of FIAU at 50 mg/kg per day as divided doses beginning 48 h after virus inoculation prevented the development of evidences of clinical infection. Oral treatment with FIAU at 30 mg/kg per day deferred as late as 7 days after virus inoculation modified the course of the disease. When treatment was started 48 h after virus inoculation, daily doses of FIAU as small as 1 mg/kg inhibited development of infections; daily doses of 0.2 mg/kg were ineffective. At the latter dose FMAU prevented development of clinical disease, suggesting that it was more active than FIAU. No signs of FIAU toxicity were observed, with the single exception of an early but transitory elevation in aspartate aminotransferase activity in serum.

Full text

PDF
20

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen W. P., Felsenfeld A. D., Wolf R. H., Smetana H. F. Recent studies on the isolation and characterization of Delta herpesvirus. Lab Anim Sci. 1974 Feb;24(1):222–228. [PubMed] [Google Scholar]
  2. De Clercq E. Comparative efficacy of antiherpes drugs in different cell lines. Antimicrob Agents Chemother. 1982 Apr;21(4):661–663. doi: 10.1128/aac.21.4.661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Felsenfeld A. D., Abee C. R., Gerone P. J., Soike K. F., Williams S. R. Phosphonoacetic acid in the treatment of simian varicella. Antimicrob Agents Chemother. 1978 Sep;14(3):331–335. doi: 10.1128/aac.14.3.331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Felsenfeld A. D., Schmidt N. J. Immunological relationship between delta herpesvirus of patas monkeys and varicells-zoster virus of humans. Infect Immun. 1975 Aug;12(2):261–266. doi: 10.1128/iai.12.2.261-266.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Lopez C., Watanabe K. A., Fox J. J. 2'-fluoro-5-iodo-aracytosine, a potent and selective anti-herpesvirus agent. Antimicrob Agents Chemother. 1980 May;17(5):803–806. doi: 10.1128/aac.17.5.803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Mayo D. R., Hsiung G. D. Treatment of primary acute genital herpes in guinea pigs by intraperitoneal administration of fluoropyrimidines. Antimicrob Agents Chemother. 1984 Sep;26(3):354–357. doi: 10.1128/aac.26.3.354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Merluzzi V. J., Last-Barney K., Fox J. J. Comparison of 2'-fluoro-arabinosyl pyrimidine nucleosides and 1-beta-D-arabinofuranosylcytosine on immunological parameters in vitro. Int J Immunopharmacol. 1983;5(5):421–425. doi: 10.1016/0192-0561(83)90017-6. [DOI] [PubMed] [Google Scholar]
  8. Roberts E. D., Baskin G. B., Soike K., Gibson S. V. Pathologic changes of experimental simian varicella (Delta herpesvirus) infection in African green monkeys (Cercopithecus aethiops). Am J Vet Res. 1984 Mar;45(3):523–530. [PubMed] [Google Scholar]
  9. Schinazi R. F., Peters J., Sokol M. K., Nahmias A. J. Therapeutic activities of 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-iodocytosine and -thymine alone and in combination with acyclovir and vidarabine in mice infected intracerebrally with herpes simplex virus. Antimicrob Agents Chemother. 1983 Jul;24(1):95–103. doi: 10.1128/aac.24.1.95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Soike K. F., Felsenfeld A. D., Gerone P. J. Acyclovir treatment of experimental simian varicella infection of monkeys. Antimicrob Agents Chemother. 1981 Sep;20(3):291–297. doi: 10.1128/aac.20.3.291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Soike K. F., Gerone P. J. Acyclovir in the treatment of simian varicella virus infection of the African green monkey. Am J Med. 1982 Jul 20;73(1A):112–117. doi: 10.1016/0002-9343(82)90075-4. [DOI] [PubMed] [Google Scholar]
  12. Trousdale M. D., Nesburn A. B., Su T. L., Lopez C., Watanabe K. A., Fox J. J. Activity of 1-(2'-fluoro-2'-deoxy-beta-D-arabinofuranosyl)thymine against herpes simplex virus in cell cultures and rabbit eyes. Antimicrob Agents Chemother. 1983 Jun;23(6):808–813. doi: 10.1128/aac.23.6.808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Watanabe K. A., Reichman U., Hirota K., Lopez C., Fox J. J. Nucleosides. 110. Synthesis and antiherpes virus activity of some 2'-fluoro-2'-deoxyarabinofuranosylpyrimidine nucleosides. J Med Chem. 1979 Jan;22(1):21–24. doi: 10.1021/jm00187a005. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES